Nintedanib benefits patients with autoimmune disease-related lung diseases Hina Zahid12 March 2022 9:00 AM ISTA new clinical published in Arthritis & Rheumatology reveals that nintedanib, a medication that helps prevent changes to lung tissue, may help...
Promising Benefits of Nintedanib in Minimizing COVID Induced Lung Injury in mechanically ventilated patients: Results from a Pilot Study Dr. JUDO JOSEPH VACHAPARAMBIL11 Sept 2021 12:45 PM ISTNew Delhi: The COVID-19 pandemic has been unrelenting for the last year and a half. Globally, increasing numbers are added each day to the COVID-19...
JB Chemicals and Pharmaceuticals launches Nintedanib for treatment in Idiopathic Pulmonary Fibrosis (IPF) Meghna A Singhania26 Jun 2021 11:06 AM ISTMumbai: J.B. Chemicals & Pharmaceuticals Ltd. today announced the launch of 'Nintabid' Capsules containing Nintedanib 100mg and 150mg, an oral...
Cipla launches generic Idiopathic Pulmonary Fibrosis drug Nintedanib in India Ruchika Sharma21 Oct 2020 1:00 PM ISTNew Delhi: Pharma major Cipla on Tuesday said it has launched generic Nintedanib used for the treatment of Idiopathic Pulmonary Fibrosis (IPF) under...
BDR Pharma unveils idiopathic pulmonary fibrosis drug Nintedanib in India Ruchika Sharma20 Oct 2020 11:06 AM ISTIPF is lung disorder where there is scarring of the lungs due to an unknown cause, BDR Pharmaceuticals said in a statement.
